The Wall Street Journal has an article about using genomics to develop vaccines -- something that Novartis in particular has been developing. A vaccine for a certain form of meningitis, for instance, is showing promise in clinical trials and "Novartis plans to move [it] into a much-larger test involving thousands of children next year, says Rino Rappuoli, an Italian scientist who heads Novartis's vaccine research," according to the article.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.